percutaneous-coronary-intervention

Documents about percutaneous-coronary-intervention

• Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction#914885ClinicalTrials.gov
• Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors#670167HAL (France)
• Intramyocardial Haemorrhage in Patients With Primary STEMI#873087ClinicalTrials.gov
• Detection and Significance of Heart Injury in ST Elevation Myocardial Infarction.#908701ClinicalTrials.gov
• Viable Myocardium Detected by Hybrid PET/MR and SPECT for the Prediction of the Efficacy of PCI in Patients With CTO.#1033386ClinicalTrials.gov
• Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)#805919ClinicalTrials.gov
• Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)#812909ClinicalTrials.gov
• Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN#835584ClinicalTrials.gov
• Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction#847796ClinicalTrials.gov
• FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease#899745ClinicalTrials.gov
• Early Percutaneous Coronary Intervention (PCI) After Fibrinolysis Versus Standard Therapy in ST Segment Elevation Myocardial Infarction (STEMI) Patients#899862ClinicalTrials.gov
• Machine learning for prediction of newly diagnosed atrial fibrillation after emergency percutaneous coronary intervention during hospitalization in patients with acute ST-segment elevation myocardial infarction: a multi-center prospective study.#452896NCBI PubMed Central
• Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI)#1031312ClinicalTrials.gov
• Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk#840737ClinicalTrials.gov
• Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack#842024ClinicalTrials.gov
• Cross-sectional analysis of knowledge, attitude and practice (KAP) on postoperative health self-management in patients undergoing percutaneous coronary intervention across different time intervals postprocedure at a tertiary hospital in China.#439324NCBI PubMed Central
• Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)#966170ClinicalTrials.gov
• The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack#1030495ClinicalTrials.gov
• Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction#847887ClinicalTrials.gov
• Relation of Total Ischemic Time to Repolarization Indices and Their Impact on Outcomes Among STEMI Patients Undergoing Primary PCI#909020ClinicalTrials.gov
• Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial#912244ClinicalTrials.gov
• Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction#827801ClinicalTrials.gov
• 24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial#834094ClinicalTrials.gov
• Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials#637009PLOS
• Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients#810233ClinicalTrials.gov
• Individualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI#850478ClinicalTrials.gov
• Rheolytic Thrombectomy in Patients With Acute STEMI and Large Thrombus Burden#884321ClinicalTrials.gov
• Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery#877682ClinicalTrials.gov
• Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic Shock#886940ClinicalTrials.gov